As 2024 concludes, here are 6 significant scientific discoveries, including medical breakthroughs, space exploration, and ...

Lenacapavir, a preventive HIV drug, could become accessible in low-income countries by 2026. Efforts spearheaded by global ...

While the efficacy of twice-yearly subcutaneous lenacapavir for HIV prevention has previously been demonstrated in cisgender ...

Discover the new planets, moons, health advances, and ancient history uncovered in 2024.

Science magazine has chosen twice-yearly lenacapavir PrEP as its 2024 Breakthrough of the Year, recognizing it as a ...

By 2025, a new HIV preventive drug, lenacapavir, could be available to the world's poorest regions. The Global Fund aims to ...

GILD has put up a steady performance in 2024, with a new drug approval, positive data readouts and strong quarterly results.

Investors are bullish on Gilead as the stock surges on successful launches and strong financial health, offering potential ...

Lenacapavir is already approved for use as a treatment for multi-drug resistant HIV, costing around $42,250 for the first ...

A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global ...

The country is one of 18 others likely to get the Lenacapavir drug, which was proven to be 100 percent effective in ...

Several giant US and international groups focused on fighting HIV and AIDS on Tuesday unveiled a plan to swiftly provide ...